A two-color BCR-ABL probe that greatly reduces the false positive and false negative rates for fluorescence in situ hybridization in chronic myeloid leukemia

被引:0
|
作者
Grand, FH [1 ]
Chase, A [1 ]
Iqbal, S [1 ]
Nguyen, DX [1 ]
Lewis, JL [1 ]
Marley, SB [1 ]
Davidson, RJ [1 ]
Goldman, JM [1 ]
Gordon, MY [1 ]
机构
[1] Hammersmith Hosp, Imperial Coll, Sch Med, Dept Haematol, London W12 0NN, England
来源
GENES CHROMOSOMES & CANCER | 1998年 / 23卷 / 02期
关键词
D O I
10.1002/(SICI)1098-2264(199810)23:2<109::AID-GCC3>3.3.CO;2-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The t(9;22) translocation resulting in the fusion of BCR and ABL genes is pathognomonic in chronic myeloid leukemia (CML) and may be investigated at the molecular level using fluorescence in situ hybridization (FISH). Two-color BCR-ABL probes visualizing one fusion signal (1F FISH) have high false positive rates (FPR) and false negative rates (FNR). The FPR is a result of the random spatial association of probe signals within normal interphase cells so that some cells appear to contain the BCR-ABL fusion gene. The FNR of 1F FISH probes depends on the distance between the BCR and ABL probes hybridized to the BCR-ABL fusion gene (less than or equal to 368 kb); the "gap" between the signals causing the cell to be interpreted as normal. To overcome there difficulties, a two-color probe was used. employing four yeast artificial chromosome (YAC) sequences that span the breakpoint regions of the BCR and ABL genes and that visualize the two fusion signals BCR-ABL and ABL-BCR in CML cells (2F FISH). The FNR for the 2F FISH probes was assessed on clonal Ph+ granulocyte-macrophage-colony-forming cell (CFU-GM) derived colonies and was reduced to 0.4% (2/450), compared with an FNR of 13.5% (111/823) with 1F FISH. The FPR in normal mononuclear cells for the 2F FISH was 0.19 +/- 0.12% (3/1,700), whereas the FPR using 1F FISH was 4.5 +/- 2.3% (63/1,294). The 2F FISH can thus be used to evaluate very small frequencies of BCR-ABL-positive and -negative interphase cells and may be of use in the clinical monitoring of CML. (C) 1998 Wiley-Liss, Inc.
引用
收藏
页码:109 / 115
页数:7
相关论文
共 50 条
  • [1] Factors influencing the false positive and negative rates of BCR-ABL fluorescence in situ hybridization
    Chase, A
    Grand, F
    Zhang, JG
    Blackett, N
    Goldman, J
    Gordon, M
    GENES CHROMOSOMES & CANCER, 1997, 18 (04): : 246 - 253
  • [2] A novel two color BCR/ABL probe reduces the false positive rate for fluorescence in situ hybridisation (FISH) below 0.5%.
    Grand, FH
    Chase, A
    Iqbal, S
    Nguyen, DX
    Lewis, JL
    Marley, SB
    Goldman, JM
    Gordon, MY
    BLOOD, 1997, 90 (10) : 2235 - 2235
  • [3] Identification of BCR-ABL fusion on chromosome 9 by fluorescence in situ hybridization in two chronic myeloid leukemia cases
    Abruzzese, E
    Pettenati, MJ
    Cox, K
    Jackle, B
    Watts, RG
    Carroll, AJ
    Steuterman, MC
    Rao, PN
    CANCER GENETICS AND CYTOGENETICS, 1998, 105 (02) : 164 - 167
  • [4] Fluorescence in situ hybridization characterization of different cryptic BCR-ABL rearrangements in chronic myeloid leukemia
    Haigh, S
    Cuthbert, G
    CANCER GENETICS AND CYTOGENETICS, 2004, 155 (02) : 132 - 137
  • [5] Near-haploid blast phase in a chronic myeloid leukemia detected by fluorescence in situ hybridization using a BCR-ABL probe
    Gancberg, D
    Dargent, JL
    Verhest, A
    Kentos, A
    Feremans, W
    Lohrisch, C
    Kornreich, A
    CANCER GENETICS AND CYTOGENETICS, 2001, 128 (02) : 172 - 174
  • [6] A Ph-negative chronic myeloid leukemia patient with a non-classical BCR-ABL rearrangement characterized by fluorescence in situ hybridization
    Estop, AM
    Sherer, C
    Cieply, K
    Groft, D
    Burcoglu, A
    Jhanwar, S
    Thomas, J
    CANCER GENETICS AND CYTOGENETICS, 1997, 96 (02) : 174 - 176
  • [7] Progression of Philadelphia positive chronic myeloid leukemia to Philadelphia negative and bcr-abl positive disease
    Zivanovic, Biljana Todoric
    Strnad, Milica
    Stamatovic, Dragana
    Elez, Marija
    CHROMOSOME RESEARCH, 2013, 21 : S105 - S106
  • [8] Does pretreatment fluorescence in situ hybridization for BCR-ABL predict imatinib-associated hematologic toxicity in chronic myeloid leukemia?
    Lima, Lisa M.
    Sampat, Keeran
    Assouline, Sarit
    Saxe, Debra
    Nault, Sharron
    Tighiouart, Mourad
    McLemore, Morgan
    Arellano, Martha
    Winton, Elliott
    Bernal-Mizrachi, Leon
    Cortes, Jorge
    Khoury, Hanna Jean
    LEUKEMIA & LYMPHOMA, 2011, 52 (06) : 1010 - 1016
  • [9] YAC probe detection of rearrangement of BCR gene in chronic myeloid leukemia by fluorescence in situ hybridization
    Liu, XL
    Zhou, SY
    Song, LL
    Zheng, WY
    Liu, QF
    Chen, SJ
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 462 - 462
  • [10] Fluorescence in situ hybridization characterization of different cryptic BCR-ABL rearrangements in chronic myeloid leukemia (vol 155, pg 132, 2004)
    Haigh, S
    Cuthbert, G
    CANCER GENETICS AND CYTOGENETICS, 2005, 156 (02) : 188 - 189